Dual ACE and NEP inhibitors: A review of the pharmacological properties of MDL 100,240ROSSI, Gian Paolo.Cardiovascular drug reviews (Print). 2003, Vol 21, Num 1, pp 51-66, issn 0897-5957, 16 p.Article

A testbed environment for the performance evaluation of modular network architecturesMAGGIORINI, Dario; PAGANI, Elena; ROSSI, Gian Paolo et al.European conference on universal multiservice networks. 2000, pp 283-292, isbn 0-7803-6419-8Conference Paper

Analysis and evaluation of QoS-sensitive multicast routing policiesPAGANI, Elena; ROSSI, Gian Paolo.Lecture notes in computer science. 2001, issn 0302-9743, isbn 3-540-42302-8, 2Vol, vol 1, 468-477Conference Paper

A functional architecture for end-to-end quality-of-service in a multi-domain networkPAGANI, Elena; ROSSI, Gian Paolo.European conference on universal multiservice networks. 2000, pp 20-34, isbn 0-7803-6419-8Conference Paper

The endothelin-aldosterone axis and cardiovascular diseasesROSSI, Gian Paolo; CAVALLIN, Martina; NUSSDORFER, Gastone G et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S49-S52Conference Paper

The role of adrenal venous sampling in the surgical management of primary aldosteronismTONIATO, Antonio; BERNANTE, Paolo; ROSSI, Gian Paolo et al.World journal of surgery. 2006, Vol 30, Num 4, pp 624-627, issn 0364-2313, 4 p.Article

Proceedings of the meeting new insights and therapeutic strategies in cardiovascular disease: focus on endothelial targets, Venice, Italy, April 28-29, 2000PESSINA, Achille C; LüSCHER, Thomas F; ROSSI, Gian Paolo et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, 89 p.Conference Proceedings

A thoracic mass with hypertension and hypokalaemiaROSSI, Gian Paolo; VENDRAMINELLI, Roberto; CESARI, Maurizio et al.Lancet (British edition). 2000, Vol 356, Num 9241, issn 0140-6736, p. 1570Article

Endothelins and Cardiovascular Disease: Proceedings of a satellite symposium to the 17th Scientific Meeting of the International Society of Hypertension, Padua, Italy, June 12-13, 1998ROSSI, Gian Paolo; LüSCHER, Thomas F; PESSINA, Achille C et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, 86 p.Conference Proceedings

Molecular interactions of vasoactive systems in cardiovascular damageBADER, Michael.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S7-S9Conference Paper

Are selective endothelin A receptor antagonists better than mixed antagonists?BAGNALL, Alan; WEBB, David.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S43-S46Conference Paper

Quality-of-service guarantees for multicast traffic in heterogeneous multi-service networksBORELLA, Andrea; CANCELLIERI, Giovanni; PAGANI, Elena et al.Lecture notes in computer science. 2001, pp 97-112, issn 0302-9743, isbn 3-540-41512-2Conference Paper

Endothelin and pulmonary hypertensionCHEN, Yiu-Fai; OPARIL, Suzanne.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S49-S53Conference Paper

Transgenic models for the study of endothelin function in the cardiovascular systemZOLLMANN, Frank S; PAUL, Martin.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S13-S16Conference Paper

A multicast transport service with bandwidth guarantees for Diff-Serv networksPAGANI, Elena; ROSSI, Gian Paolo; MAGGIORINI, Dario et al.Lecture notes in computer science. 2001, pp 129-140, issn 0302-9743, isbn 3-540-41512-2Conference Paper

Mobility Timing for Agent Communities, a Cue for Advanced Connectionist SystemsAPOLLONI, Bruno; BASSIS, Simone; PAGANI, Elena et al.IEEE transactions on neural networks. 2011, Vol 22, Num 12, pp 2032-2049, issn 1045-9227, 18 p., 1Article

Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases. Editorial commentCESARI, Maurizio; ROSSI, Gian Paolo; PESSINA, Achille Cesare et al.Journal of hypertension. 2002, Vol 20, Num 5, pp 793-799, issn 0263-6352, 10 p.Article

Endothelin receptor blockade and in-stent restenosisKIRCHENGAST, Michael.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S31-S34Conference Paper

Endothelin : Role in experimental hypertensionSCHIFFRIN, Ernesto L.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S33-S35Conference Paper

Endothelin and endothelin receptor antagonism in heart failureSÜTSCH, Gabor; KIOWSKI, Wolfgang.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S69-S73Conference Paper

The endothelin family : An overviewMASAKI, Tomoh.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S3-S5Conference Paper

Adrenal vein sampling for primary aldosteronism : the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulationROSSI, Gian Paolo; PITTER, Gisella; BERNANTE, Paolo et al.Journal of hypertension. 2008, Vol 26, Num 5, pp 989-997, issn 0263-6352, 9 p.Article

A critical review of the role of endothelial factors in the pathogenesis of hypertensionSCHIFFRIN, Ernesto L.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S3-S6Conference Paper

Endothelial factors and microvascular hypertensive diseaseRIZZONI, Damiano; AGABITI-ROSEI, Enrico.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S15-S18Conference Paper

New insight and therapeutic strategies in cardiovascular disease and focus on endothelial target: Endothelin- 1 and anginaLERMAN, Amir.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S27-S30Conference Paper